Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Perspectives on anti-HER monoclonal antibodies.
Ranson M, Sliwkowski MX. Ranson M, et al. Among authors: sliwkowski mx. Oncology. 2002;63 Suppl 1:17-24. doi: 10.1159/000066203. Oncology. 2002. PMID: 12422051 Review.
Preclinical studies with Erlotinib (Tarceva).
Akita RW, Sliwkowski MX. Akita RW, et al. Among authors: sliwkowski mx. Semin Oncol. 2003 Jun;30(3 Suppl 7):15-24. Semin Oncol. 2003. PMID: 12840797 Review.
A potential role for activated HER-2 in prostate cancer.
Agus DB, Akita RW, Fox WD, Lofgren JA, Higgins B, Maiese K, Scher HI, Sliwkowski MX. Agus DB, et al. Among authors: sliwkowski mx. Semin Oncol. 2000 Dec;27(6 Suppl 11):76-83; discussion 92-100. Semin Oncol. 2000. PMID: 11236032 Review.
Structural requirements for ErbB2 transactivation.
Penuel E, Schaefer G, Akita RW, Sliwkowski MX. Penuel E, et al. Among authors: sliwkowski mx. Semin Oncol. 2001 Dec;28(6 Suppl 18):36-42. Semin Oncol. 2001. PMID: 11774204 Review.
CD20: a gene in search of a function.
Riley JK, Sliwkowski MX. Riley JK, et al. Among authors: sliwkowski mx. Semin Oncol. 2000 Dec;27(6 Suppl 12):17-24. Semin Oncol. 2000. PMID: 11225995 Review.
A two-in-one antibody against HER3 and EGFR has superior inhibitory activity compared with monospecific antibodies.
Schaefer G, Haber L, Crocker LM, Shia S, Shao L, Dowbenko D, Totpal K, Wong A, Lee CV, Stawicki S, Clark R, Fields C, Lewis Phillips GD, Prell RA, Danilenko DM, Franke Y, Stephan JP, Hwang J, Wu Y, Bostrom J, Sliwkowski MX, Fuh G, Eigenbrot C. Schaefer G, et al. Among authors: sliwkowski mx. Cancer Cell. 2011 Oct 18;20(4):472-86. doi: 10.1016/j.ccr.2011.09.003. Cancer Cell. 2011. PMID: 22014573 Free article.
The biology of human epidermal growth factor receptor 2.
Sundaresan S, Penuel E, Sliwkowski MX. Sundaresan S, et al. Among authors: sliwkowski mx. Curr Oncol Rep. 1999 Sep;1(1):16-22. doi: 10.1007/s11912-999-0005-7. Curr Oncol Rep. 1999. PMID: 11122793 Review.
Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.
Makhija S, Amler LC, Glenn D, Ueland FR, Gold MA, Dizon DS, Paton V, Lin CY, Januario T, Ng K, Strauss A, Kelsey S, Sliwkowski MX, Matulonis U. Makhija S, et al. Among authors: sliwkowski mx. J Clin Oncol. 2010 Mar 1;28(7):1215-23. doi: 10.1200/JCO.2009.22.3354. Epub 2009 Nov 9. J Clin Oncol. 2010. PMID: 19901115 Clinical Trial.
110 results